Omeros Stock Skyrockets: Novo Nordisk Seals Massive $2.1 Billion Rare Disease Drug Deal
Mattel Unleashes Iconic Worlds: Barbie, Hot Wheels, and More Zoom into the Roblox Metaverse!
Merck's Breakthrough: Islatravir-Doravirine Matches Leading HIV Treatment in Pivotal Trials
Humana's Billion-Dollar Setback: Court Upholds CMS Medicare Advantage Rating Changes
Takeda and Nabla Bio Forge $1 Billion Alliance to Revolutionize Antibody Design with AI
A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients
China's Bold Gambit: New K-Visa Program Ignites Global Talent War Amidst US H-1B Curbs
Warning Bells Ring: The Buffett Indicator Flashes 'Playing with Fire' Levels
AstraZeneca's Bold Leap: Simplifying US Investment with a Direct Nasdaq Listing
BP Unleashes $5 Billion Deepwater Giant in Gulf of Mexico
Market Movers Revealed: Unpacking Last Week's Large-Cap Triumphs!
Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File
Micron's AI Revolution: CEO Sanjay Mehrotra Declares AI the Undeniable Catalyst for Record-Breaking Growth
European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases
Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid
DRC Unveils Game-Changing Cobalt Export System: A New Era for the Global Market
Billionaire David Tepper: Why He Hates This Market But Won't Challenge the Fed
A Beacon of Hope: Regeneron's Pozelimab Shines in Ultra-Rare Genetic Disorder Study
The Billionaire's Gaze: How Palantir's Valuation Inspired Marc Benioff to Rethink Salesforce's Price Tag
A New Horizon in Bladder Cancer Treatment: J&J's Balversa Secures Full FDA Approval
The Weight of Success: Why Breakthrough Obesity Drugs Are a Budget Breaker
Equity Mutual Fund Inflows Dip 21% in August, But SIPs Soar to New High
Oracle Defies Gravity: Why Its Stock Soared After a Q1 Earnings 'Miss'
Navigating the Cosmic Currents: Planet Labs Soars, EchoStar Eyes Starlink, and AST SpaceMobile Faces Turbulence
UnitedHealthcare Expands Glaucoma Treatment Access by Covering Sight Sciences' OMNI System
PTC Therapeutics: A New Titan Rising to Challenge BioMarin's Reign in Rare Disease Treatment
Summit Therapeutics' Lung Cancer Hope Faces Fierce Competition and Scrutiny
Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status
Europe's Staggering $3.5 Billion Fine Rocks Google, Ignites Trump's Call for American Investment
The Looming Uranium Crisis: Will Nuclear Power's Ambitions Be Derailed by 2030?
Salesforce's AI Aspirations: A Revolution or Just a Ripple?
A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress
Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling
Amazon Unveils 'Quick Suite': Igniting the Next Generation of AI Agents for a Smarter Future
Merck's Game-Changing Oral Pill Poised to Revolutionize Cholesterol Treatment
AstraZeneca's Baxdrostat: A Beacon of Hope in the Fight Against Uncontrolled High Blood Pressure
Microsoft Unveils $6 Billion Digital Transformation for US Government
Wegovy Triumphs: Novo Nordisk's Obesity Drug Significantly Cuts Heart Attack and Stroke Risk, Setting a New Benchmark in Cardiovascular Protection
Activist Giant Elliott Management Stirs the Pot at PepsiCo: A Call for Transformative Change
A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy
Unlocking Value: Why Analysts See Further Divestitures on Medtronic's Horizon
Oscar Health's Tumultuous Ride: What's Driving the Stock's Plummet?
Nifty LargeMidcap 250: Navigating Market Dynamics on August 20, 2025